Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis

Title
Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis
Authors
Keywords
Castration-resistant prostate cancer, Enzalutamide, Abiraterone, Docetaxel, Survival, PSA
Journal
EUROPEAN UROLOGY
Volume 68, Issue 2, Pages 317-324
Publisher
Elsevier BV
Online
2014-08-06
DOI
10.1016/j.eururo.2014.07.028

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now